Market Analysis and Price Projections for the Drug NDC: 31722-0856
Introduction to Camber Pharmaceuticals and NDC 31722-0856
Camber Pharmaceuticals, Inc., identified by the National Drug Code (NDC) labeler code 31722, is a manufacturer and distributor of a wide range of pharmaceutical products. One of the drugs they produce is Eszopiclone, which is assigned the NDC code 31722-0856. Eszopiclone is a nonbenzodiazepine hypnotic agent used primarily for the treatment of insomnia.
Current Market Landscape
The pharmaceutical market, particularly for generic and specialty drugs, is experiencing significant changes and challenges.
Drug Price Inflation
According to Vizient, Inc., the pharmacy market is projected to see a 3.8% increase in drug prices, driven largely by specialty pharmaceuticals. This trend indicates that even generic drugs, like those produced by Camber Pharmaceuticals, could be affected by broader market dynamics[2].
Generic and Biosimilar Competition
The life sciences industry is facing increased competition from generic drugs and biosimilars. This competition is expected to impact pricing strategies, as companies like Camber Pharmaceuticals navigate the market. Nearly 37% of C-suite executives view competition from generics and biosimilars as a top trend[3].
Patent Cliff and Market Impact
The biopharma industry is facing a substantial loss of exclusivity due to expiring patents, which could drive interest in mergers and acquisitions. However, for generic drugs like Eszopiclone, the patent status is already resolved, allowing multiple manufacturers to produce the drug. This competition can help stabilize or reduce prices[3].
Price Projections for Eszopiclone (NDC 31722-0856)
Generic Drug Pricing Trends
Generic drugs, such as Eszopiclone, typically experience stable or decreasing prices due to competition among multiple manufacturers. The presence of several generic versions of Eszopiclone in the market helps to keep prices competitive.
Market Growth and Demand
The US pharmaceutical market is projected to grow significantly, reaching $1.28 trillion by 2030, with a Compound Annual Growth Rate (CAGR) of 5.36% from 2022 to 2030. This growth is driven by various factors, including increased pharmaceutical production capacity and greater approvals of generic drugs. However, the specific price projection for Eszopiclone would likely remain stable or see minimal increases due to its generic status[4].
Specialty vs. Generic Pricing
While specialty pharmaceuticals are expected to see a higher price increase of 4.18%, generic drugs like Eszopiclone are less likely to follow this trend. The pricing for generic drugs is generally more stable and influenced by competition rather than the high-cost drivers associated with specialty medications[2].
Factors Influencing Price Stability
Regulatory Environment
The FDA's regulatory framework ensures that generic drugs meet the same standards as their brand-name counterparts. This regulation helps maintain quality and safety, which can influence pricing stability[5].
Supply Chain and Manufacturing
Efficiencies in supply chain management and manufacturing processes can also impact pricing. Companies that optimize their production and distribution networks can often maintain or reduce prices without compromising profitability.
Market Competition
The presence of multiple generic manufacturers for Eszopiclone ensures that prices remain competitive. Camber Pharmaceuticals, along with other manufacturers, must balance pricing with market demand and competition to maintain market share.
Conclusion
Given the current market trends and the generic status of Eszopiclone (NDC 31722-0856), it is likely that the price of this drug will remain relatively stable. Here are some key points to consider:
- Generic Competition: Multiple manufacturers producing Eszopiclone will keep prices competitive.
- Market Growth: The overall pharmaceutical market growth does not directly translate to significant price increases for generic drugs.
- Regulatory and Supply Chain Efficiencies: These factors contribute to stable pricing.
Key Takeaways
- The price of Eszopiclone (NDC 31722-0856) is expected to remain stable due to generic competition.
- The broader pharmaceutical market is seeing a 3.8% price increase, but this is more relevant to specialty drugs.
- Regulatory and supply chain efficiencies support stable pricing for generic drugs.
- The US pharmaceutical market is projected to grow significantly, but this growth is driven more by specialty and innovative therapies.
FAQs
Q: What is the NDC code for Eszopiclone produced by Camber Pharmaceuticals?
A: The NDC code for Eszopiclone produced by Camber Pharmaceuticals is 31722-0856.
Q: Why are drug prices projected to increase in 2024?
A: Drug prices are projected to increase by 3.8% in 2024, driven largely by the increasing utilization of specialty pharmaceuticals and the expansion of gene therapies[2].
Q: How does the generic status of Eszopiclone affect its pricing?
A: The generic status of Eszopiclone means that multiple manufacturers produce the drug, leading to competitive pricing and stability in the market.
Q: What is the projected growth of the US pharmaceutical market?
A: The US pharmaceutical market is projected to grow from $846.72 billion in 2022 to $1.28 trillion by 2030, with a CAGR of 5.36%[4].
Q: How do regulatory and supply chain efficiencies impact the pricing of generic drugs?
A: Regulatory and supply chain efficiencies help maintain quality and reduce costs, contributing to stable pricing for generic drugs like Eszopiclone.
Sources
- FindACode: Camber Pharmaceuticals, Inc. - List of Drugs - NDC Labeler.
- Vizient Inc.: Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals.
- Deloitte Insights: 2025 life sciences outlook.
- GlobeNewswire: US Pharmaceutical Market Review 2020-2023 and Forecast 2024-2030.
- FDA: National Drug Code Database Background Information.
